Impact of core biopsy on the management of screen-detected ductal carcinoma in situ of the breast

ANZ Journal of Surgery

Volumn 73, Issue 6, 2003, Pages 404-406

  Cheng, Michael S P ^a   Fox, Jane ^a   Hart, Stewart A ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Breast conserving surgery; Intraductal carcinoma; Mass screening; Needle biopsy

Indexed keywords

ASPIRATION CYTOLOGY; BREAST BIOPSY; BREAST CALCIFICATION; BREAST CARCINOMA; CANCER CYTODIAGNOSIS; CARCINOMA IN SITU; DATA BASE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; STEREOTAXIC SURGERY; TUMOR BIOPSY;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS;

EID: 0042346319     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-2197.2003.t01-1-02656.x     Document Type: Review

References (18)

1. Rosner D, Bedwani RN, Vana PHJ, Baker HW, Murphy GP. Non-invasive breast carcinoma. Results of a national survey by the American College of Surgeons. Ann. Surg. 1980; 192: 139-47.
2. BreastScreen Victoria. Annual Statistical Report. Melbourne: BreastScreen Victoria, 2000; 37-8.
3. Serpell JW, Johnson WR. Pre-operative histological diagnosis of breast cancer. ANZ J. Surg. 1997; 67: 325-9.
4. Nguyen M, McCombs MM, Ghanderi S et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer 1996; 78: 2340-5.
5. Stomper PC, Connelly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography. Analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989; 172: 235-41.
6. Meyer JE, Smith DN, Lester SC et al. Large-core needle biopsy of non-palpable breast lesions. JAMA 1999; 281: 1638-41.
7. Frayne J, Sterrett GF, Harvery J et al. Stereotactic 14-gauge core-biopsy of the breast: results from 101 patients. ANZ J. Surg. 1996; 66: 585-91.
8. Liberman L, Dershaw DD, Rosen PP, Abramson AF, Deutch BM, Hann LE. Stereotactic 14-gauge breast biopsy: how many core biopsy specimens are needed? Radiology 1994; 192: 793-5.
9. Yim JH, Barton P, Weber B et al. Mammographically detected breast cancer: benefits of stereotactic core versus wire localization biopsy. Ann. Surg. 1996; 223: 688-700.
10. Mokbel K, Ahmed M, Nash A, Sacks N. Re-excision operations in non-palpable breast cancer. J. Surg. Oncol. 1995; 58: 225-8.
11. Fisher B, Dignam J, Wolmark N et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17. J. Clin. Oncol. 1998; 16: 441-52.
12. Silverstein MJ, Lagios MD, Groshen S et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N. Engl. J. Med. 1999; 340: 1455-61.
13. Holland R, Hendricks JHCL, Verbeek ALM, Mravunac M, Schuurmans Stekhoven JH. Extent, distribution and mammographic/ histological corrections of breast ductal carcinoma in situ. Lancet 1990; 335: 519-22.
14. Silverstein MJ, Gierson ED, Colburn WJ et al. Can intraductal breast carcinoma be excised completely by local excision? Cancer 1994; 73: 2985-9.
15. Silverman JF, Masood S, Ducatman BS, Wang HH, Sneige N. Can FNA biopsy separate atypical hyperplasia, carcinoma in situ and invasive carcinoma of the breast. Diag. Cytopathol. 1993; 9: 713-28.
16. Poole GH, Willsher PC, Pinder SE, Robertson JF, Elston CW, Blamey RW. Diagnosis of breast cancer with core-biopsy and fine needle aspiration cytology. ANZ J. Surg. 1996; 66: 592-4.
17. Cangiarella J, Waisman J, Symmans WF et al. Mammotome core biopsy for mammary calcification: analysis of 160 biopsies from 142 women with surgical and radiologic followup. Cancer 2001; 91: 173-7.
18. Cangiarella J, Gross J, Symmans WF et al. The incidence of positive margins with breast conserving therapy following mammotome biopsy for microcalcification. J. Surg. Oncol. 2000; 74: 263-6.